Global Optogenetics Market – Industry Trends and Forecast to 2030

 Optogenetics Market Analysis and Size

According to the Parkinson's Foundation 2020, approximately 1.2 million people in the United States may have Parkinson's disease by 2030. Furthermore, according to the Alzheimer Society of Canada 2021, over 500,000 Canadians were living with dementia. This number is expected to rise to 912,000 by 2030. According to the Public Health Agency of Canada News release 2019, nine seniors are diagnosed with dementia in Canada every hour. According to the National Institutes of Health, the estimated investment for neurosciences in 202 is USD 10,353 million in May 2020, a significant increase from the USD 10,353 million figures in 2020. The growing investment in neuroscience is expected to increase the demand for optogenetics, a novel method of identifying neurological disorders. This factor is expected to boost the market’s growth.

Data Bridge Market Research analyses that the optogenetics market which is USD 0.31 billion in 2022, is expected to reach USD 1.11 billion by 2030, at a CAGR of 17.35% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Optogenetics Market Scope and Segmentation  

Market Definition

Optogenetics is a scientific methodology that combines genetics and optical technologies. It is mostly used to manage and control the biological processes of neurons and other light-sensitive cells. Individual behaviour and physiology, such as locomotion, learning, memory, navigation, metabolism, respiration, and sensor processing, are better understood with this knowledge. Optogenetics contributes to clinical discoveries by illuminating the neuronal processes involved in a variety of disorders such as drug addiction, obsessive compulsion disorder (OCD), Parkinson's disease, stroke, chronic pain, epilepsy, social dysfunction, anxiety, and depression.

Optogenetics Market Dynamics

Drivers

• Rise in chronic diseases

According to the National Center for Chronic Disease Prevention and Health Promotion (January 2021), four o​​​​​​​ut of every ten adults in the United States have two or more chronic diseases, and six out of every ten adults have one or more chronic diseases. These diseases cost the country's healthcare system USD 3.8 trillion per year, which could significantly impact the industry's development under consideration. Rising government initiatives are the primary drivers of growth in the neurological field. With more investment, more businesses can enter the market and provide innovative solutions to patient needs.

• Increasing patient population

According to the Alzheimer's Impact Movement study from July 2020, more than 5 million Americans have Alzheimer's disease, and an estimated 16 million are looking for unpaid care. Alzheimer's disease will cost the country USD 305 billion in 2020, with Medicare and Medicaid payments accounting for USD 206 billion. More care is required for the growing patient population, increasing the optogenetics demand and accelerating market growth.

• Collaborations and agreements

Partnerships and agreements are another factor driving market growth. For instance, in September 2021, NeuroLux Inc. announced an exclusive partnership with TSE Systems to integrate its wireless technology with TSE Systems' IntelliCage and PhenoMaster platforms, providing optogenetic, pharmacology, telemetry, and other capabilities for cutting-edge behavioural neuroscience research.

Opportunities

• Government Initiatives

The increase in government efforts in the neurological field is one of the primary drivers of market growth. As funding grows, more competitors will be able to enter the market and offer cutting-edge solutions to meet the needs of patients. According to the National Center for Chronic Disease Prevention and Health Promotion (January 2021), six out of every ten adults in the United States have a chronic disease, and four out of every ten adults have two or more chronic diseases. These conditions impose an annual burden of USD 3.8 trillion on the nation's healthcare system, which is expected to significantly impact the market's development.

Restraints/Challenges

• Less efficiency of LED’S

LEDs are generally limited to several hundred megabits per second links, whereas lasers can be 25-50 gigabits per second links when directly modulated. As a result, the low efficiency of optical fibres limits the use of LEDs in some applications.

• Awareness of optogenetics

However, the lack of awareness of optogenetics in developing economies compared to developed economies will pose a challenge to the growth of the optogenetics market.

This optogenetics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the optogenetics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Optogenetics Market

The global COVID-19 pandemic is expected to significantly impact the optogenetics market. SARS-CoV-2 has an 85% prevalence in Alzheimer's patients, according to Shanet Suzan Alex's paper for PUS University in February 2022, and causes cerebral problems in addition to respiratory symptoms. Furthermore, SARS-CoV-2 infiltrated the cognitive centres of COVID-19 patients, resulting in Alzheimer's-like phenotypes in people with no other underlying illnesses and worsening Alzheimer's neuropathology in people who already had Alzheimer's and autism, according to the same source. The COVID-19, which has been linked to neurological illnesses, has increased death rates and had a significant impact on the market.

Recent Development

• In 2020, Gensight Biologics S.A. reported that an independent Data Safety Monitoring Board had completed its second planned safety review of the ongoing PIONEER Phase I/II clinical study of GS030 (DSMB). The company's Retinitis Pigmentosa treatment combines gene therapy and optogenetics (RP). The GS030 product is based on the company's own optogenetics technology platform. The GS030 uses gene therapy to make retinal ganglion cells responsive to light and avoid disease-killed photoreceptors by injecting them with a gene code for a light-sensitive protein via a single intravitreal injection.
• In 2019, RMIT (Royal Melbourne Institute of Technology) University researchers developed a device that can mimic how the brain retains and loses information. They achieved this by drawing inspiration from optogenetics. The usage of optogenetics enables researchers to probe the body's electrical system by manipulating neurons to turn them on or off using light.

Global Optogenetics Market Scope

The optogenetics market is segmented on the basis of light equipment type, actuator, sensor and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Light Equipment Type

• Laser
• Light-emitting Diode (LED)

 Actuator

• Channelrhodopsin
• Halorhodopsin
• Archaerhodopsin

Sensor

• Calcium Aequorin
• Cameleon
• Other
• pH Sensors
• Genetically Modified Calcium Indicators
• Neurotransmitter Release
• Voltage-sensitive Fluorescent Proteins
• Chloride (Clomeleon)

• Membrane-gated (Mermaid)

Application

• Neuroscience
• Behavioral Tracking
• Retinal Disease Treatment
• Others

Optogenetics Market Regional Analysis/Insights

The optogenetics market is analyzed and market size insights and trends are provided by country, light equipment type, actuator, sensor and application as referenced above.

The countries covered in the optogenetics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the optogenetics market due to the development in the application of optogenetic tools, principally in educational and analysis labs.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the growing healthcare sector researches across the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The optogenetics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for optogenetics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the optogenetics market. The data is available for historic period 2011-2021.

Competitive Landscape and Optogenetics Market Share Analysis

The optogenetics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to optogenetics market.

Some of the major players operating in the optogenetics market are:

• Elliot Scientific Ltd (U.K.)
• Shanghai Laser & Optics Century Co. Ltd. (China)
• GenSight Biologics (France)
• Danaher (U.S.)
• Cohorent, Inc. (U.S.)
• Thorlabs, Inc. (U.S.)
• Prizmatix (Israel)
• Bruker (U.S.)
• Scientifica (U.K.)
• Judges Scientific plc (U.K.)
• Addgene (U.S.)
• THE JACKSON LABORATORY (U.S.)
• Noldus Information Technology (China)
• Merck KGaA (Germany)
• agtc (U.S.)
• Circuit Therapeutics, Inc. (U.S.)
• Laserglow technologies (Canada)
• REGENXBIO Inc. (U.S.)

SKU-53788